#CardiovascularCare #PharmaInnovation #Repatha #HeartHealth #ClinicalResearch To view or add a comment, sign in A new study presented at the European Society of Cardiology Congress 2025, powered by Truveta Data from more than 200,000 patients, found: Early discontinuation was linked to higher cardiovascular risks
Then the levels of albumin (ALB), total bilirubin (TBIL), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (-GT), triglyceride (TG), cholesterol (CHOL), glucose (GLU), urea nitrogen (BUN), and creatinine (CRE) ion Calcium (Ca), and ion Phosphote (P) were measured using the Pointcare V3 automatic biochemical analyzer (Tianjin MNCHIP Technologies Ltd., Tianjin, China) with commercial diagnostic kits
But if you think it has been exposed to high heat and you are not aware how long it was there, dont use it
Cycle Rationale Cycle rationale involves: Preventing receptor desensitization Allowing body to reset natural peptide production Maintaining copper balance to avoid accumulation Optimizing long-term efficacy Vial Requirements Per Cycle For 50 mg vials at 1-2 mg daily dosing: 2-3 vials (84-168 mg total) 3-4 vials (126-252 mg total) 4-5 vials (168-336 mg total) Storage Requirements Lyophilized powder storage optimally occurs at -20C (freezer) until reconstitution, with alternatives of 2-8C (refrigerator) or cool, dry place
After use, rehydrate with water or an electrolyte drink
Mugisha, S